The present large cross-sectional and longitudinal study showed no abnormality in EBV viral load or EBV-specific T-cell response in patients with RA or SpA at baseline or after treatment with MTX or anti-TNF drugs. This evidence concerns the gene TNF and rheumatoid arthritis.